Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iron-dependent enzymes and hemoglobin synthesis machinery refer collectively to the set of proteins and molecular complexes, primarily enzymes, required for the biosynthesis of heme and assembly of hemoglobin in erythroid cells. Key enzymes include delta-aminolevulinic acid synthase (ALAS, especially the erythroid isoform ALAS2), ferrochelatase, and others in the heme synthesis pathway, many of which require iron either as a substrate (e.g., incorporation of Fe²⁺ by ferrochelatase as the final step in making heme) or as functional cofactors (e.g., iron-sulfur clusters in enzyme structure)[1][3][4][5]. These are tightly regulated by iron availability, heme feedback, and erythroid transcription factors such as GATA-1[1][3][8]. Deficiencies or dysregulation in any of these enzymatic steps can lead to a variety of hematologic diseases, including different forms of anemia and porphyria. Collectively, this "target" is not a single protein or therapeutic entity but a pathway—thus, it is not a canonical therapeutic target but a pathway comprising multiple potential targets for intervention[3][5][7][8].
Iron provision facilitates proper function of heme biosynthetic enzymes.\nHemin provides feedback inhibition of delta-aminolevulinic acid synthase (ALAS), regulating heme synthesis[7].\nSome drugs supply missing heme or modulate globin gene expression (e.g., hydroxyurea increases fetal hemoglobin through epigenetic modulation)[8].\nIron chelators may suppress overactive iron-utilizing pathways in overload disorders.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron-dependent enzyme (hemoglobin synthesis pathway component).